BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20177282)

  • 1. Family history of venous thromboembolism and identifying factor V Leiden carriers during pregnancy.
    Horton AL; Momirova V; Dizon-Townson D; Wenstrom K; Wendel G; Samuels P; Sibai B; Spong CY; Cotroneo M; Sorokin Y; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ;
    Obstet Gynecol; 2010 Mar; 115(3):521-525. PubMed ID: 20177282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
    Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
    Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis.
    Biron-Andreani C; Schved JF; Daures JP
    Thromb Haemost; 2006 Jul; 96(1):14-8. PubMed ID: 16807645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
    Middeldorp S; Henkens CM; Koopman MM; van Pampus EC; Hamulyák K; van der Meer J; Prins MH; Büller HR
    Ann Intern Med; 1998 Jan; 128(1):15-20. PubMed ID: 9424976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
    Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden mutation and pregnancy-related complications.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Am J Obstet Gynecol; 2010 Nov; 203(5):469.e1-8. PubMed ID: 21055512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?
    Franchini M; Lippi G
    Semin Thromb Hemost; 2011 Apr; 37(3):275-9. PubMed ID: 21455861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
    Spannagl M; Heinemann LA; Schramm W
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.